Inicure particppated in the AMR conference i Basel meeting research collaborators, service providers and potential future commercial partners

Inicure has been awarded support from the INCATE network (Incubator for Antibacterial Therapies in Europe). Access to advice and

The EIC-Transition proposal — iCURE “Novel small molecule FPR1 agonists for treating antibiotic-resistant and chronic bacterial infections” coordinated

Inicure was pitched by CEO Peter Olofsson-Sahl at GoWest – Nordic capital 28-29 January 2026. Inicures approach to

Invited as presenter at the Immunotherapies & Innovations for Infectious Diseases Congress (#I4ID2025) – in Lyon, CEO of

Chairman Dr Sara Malcus and CEO Peter Olofsson-Sahl participated in the Nordic Life Science days. Reconnecting with several

Inicures founders and researchers Professor Johan Bylund at the University of Gothenburg, together with Dr. Peter Olofsson-Sahl at

CEO, Peter Olofsson-Sahl presented Inicure at the #BiotechHanse event as innovative Swedish Life Science innovation for Sweden-Germany collaboration

As partner to the IMPACT project led by University Southern Denmark (SDU) and professor Thomas Andersen, Inucure is